Active, Not Recruiting
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
NCT05211232
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- The Affiliated Hospital of Guangdong Medical College Zhanjiang, Guangdong, China
- Wuzhou Red Cross Hospital Wuzhou, Guangxi, China
- Guizhou Cancer Hospital Guiyang, Guizhou, China
- Hunan Cancer Hospital Changsha, Hunan, China